【レポートの概要（一部）】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Pipeline portfolio
• Phase III pipeline portfolio: Global CNS disorders therapeutics market
• Phase II pipeline portfolio: Global CNS disorders therapeutics market
• Phase I pipeline portfolio: Global CNS disorders therapeutics market
• Pre-clinical and discovery pipeline portfolio: Global CNS disorders therapeutics market
PART 06: Market landscape
• Market overview
• Five forces analysis
PART 07: Market segmentation by type of disease
• Global depression drugs market
• Global MS drugs market
• Global schizophrenia drugs market
• Global bipolar disorder therapeutics market
• Global AD drugs market
• Global epilepsy drugs market
• Global PD drugs market
PART 08: Geographical segmentation
• CNS disorders therapeutics market in Americas
• CNS disorders therapeutics market in EMEA
• CNS disorders therapeutics market in APAC
PART 09: Market drivers
• Special regulatory designations for CNS disorders
• New DMD approvals for AD, PD, and MS
• Development of novel therapeutics using innovative technologies
• High growth potential of mAbs
PART 10: Impact of drivers
PART 11: Market challenges
• High failure rates of late-stage products in clinical trials
• Growing use of non-invasive neuromodulation and seizure management devices
• Unavailability of standard diagnostic methods
• Increase in rehabilitation programs
• Social stigma associated with CNS diseases
PART 12: Impact of drivers and challenges
PART 13: Market trends
• Popularity of me-too drugs
• Increased uptake of new-generation drugs
• Reformulation of marketed drugs
• Focus on regenerative therapies for CNS disorders
• Increase in use of LAI antipsychotics
PART 14: Vendor landscape0
• Competitive scenario0
• Key news3
• GlaxoSmithKline7
• Pfizer2
• Eli Lilly8
• Janssen Pharmaceuticals3
• Novartis8
• Other prominent vendors4
PART 15: Appendix4
• List of abbreviations4
PART 16: Explore Technavio6
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Global CNS disorders therapeutics market snapshot
Exhibit 03: Impact of key customer segments on market 2015
Exhibit 04: Key buying criteria for CNS drugs 2015
Exhibit 05: Share of pipeline molecules in global CNS disorders therapeutics market
Exhibit 06: Prevalence of dementia in various regions (millions)
Exhibit 07: Revenues of top-selling CNS drugs (2013-2015)
Exhibit 08: Global CNS disorders therapeutics market snapshot: Developed and emerging markets 2015
Exhibit 09: Global CNS disorders therapeutics market 2015-2020 ($ billions)
Exhibit 10: Impact of drivers and challenges on global CNS disorders therapeutics market
Exhibit 11: Five forces analysis
Exhibit 12: Global CNS disorders therapeutics market: Segmentation by application (2015-2020)
Exhibit 13: Global CNS disorders therapeutics market: Segmentation by type of disease 2015
Exhibit 14: Global CNS disorders therapeutics market segmentation: Growth cycle analysis
Exhibit 15: Global depression drugs market 2015-2020 ($ billions)
Exhibit 16: Opportunity analysis of global depression drugs market
Exhibit 17: Global MS drugs market 2015-2020 ($ billions)
Exhibit 18: Opportunity analysis of global MS drugs market
Exhibit 19: Global schizophrenia drugs market 2015-2020 ($ billions)
Exhibit 20: Opportunity analysis of global schizophrenia drugs market
Exhibit 21: Global bipolar disorder therapeutics market 2015-2020 ($ billions)
Exhibit 22: Opportunity analysis of global bipolar disorder therapeutics market
Exhibit 23: Population aged 60 years and above in millions (1950-2050)
Exhibit 24: Global AD drugs market 2015-2020 ($ billions)
Exhibit 25: Opportunity analysis of global AD drugs market
Exhibit 26: Global epilepsy drugs market 2015-2020 ($ billions)
Exhibit 27: Percentage share of marketed antiepileptic drugs based on mechanism of action
Exhibit 28: Opportunity analysis of global epilepsy drugs market
Exhibit 29: Global PD drugs market 2015-2020 ($ billions)
Exhibit 30: Opportunity analysis of global PD drugs market
Exhibit 31: Global CNS disorders therapeutics market: Geography outlook (2015-2020)
Exhibit 32: Global CNS disorders therapeutics market: Geography outlook 2015
Exhibit 33: Global CNS disorders therapeutics market segmentation by geography: Market growth lifecycle analysis 2015
Exhibit 34: Global CNS disorders market revenue/growth outlook in different countries/regions 2015
Exhibit 35: Global CNS disorders therapeutics market segmentation by geography 2015-2020 ($ billions)
Exhibit 36: Opportunity analysis of CNS disorders therapeutics market in Americas
Exhibit 37: Projected prevalence rates of AD in Americas (2010-2050) (millions)
Exhibit 38: CNS disorders therapeutics market in Americas 2015-2020 ($ billions)
Exhibit 39: Percentage share of CNS disorders therapeutics market in Americas by geography 2015
Exhibit 40: Opportunity analysis of CNS disorders therapeutics market in EMEA
Exhibit 41: CNS disorders therapeutics market in EMEA 2015-2020 ($ billions)
Exhibit 42: Opportunity analysis of CNS disorders therapeutics market in APAC
Exhibit 43: CNS disorders therapeutics market in APAC 2015-2020 ($ billions)
Exhibit 44: Few of the late-stage mAbs under development for various CNS disorders
Exhibit 45: Impact of drivers
Exhibit 46: Common disorders that co-exist with bipolar disorder
Exhibit 47: Impact of drivers and challenges
Exhibit 48: Impact of trends on global CNS disorders therapeutics market
Exhibit 49: Planned clinical trials of iPS cell-based therapies
Exhibit 50: Position of key vendors in the global CNS disorders therapeutics market 2015
Exhibit 51: Geographical presence of key vendors
Exhibit 52: Company portfolio analysis in global CNS disorders therapeutics market 2016-2020
Exhibit 53: GlaxoSmithKline: Profile
Exhibit 54: GlaxoSmithKline: Sales of top-selling CNS drugs ($ millions)
Exhibit 55: GlaxoSmithKline: Metrics analysis
Exhibit 56: GlaxoSmithKline: Growth strategy matrix
Exhibit 57: GlaxoSmithKline: Opportunity assessment
Exhibit 58: Pfizer: Profile
Exhibit 59: Sales of CNS drugs ($ millions)
Exhibit 60: Pfizer: Metrics analysis
Exhibit 61: Pfizer: Growth strategy matrix
Exhibit 62: Pfizer: Opportunity assessment
Exhibit 63: Eli Lilly: Profile
Exhibit 64: Eli Lilly: Sales of top-selling CNS drugs ($ millions)
Exhibit 65: Eli Lilly: Metrics analysis
Exhibit 66: Eli Lilly: Growth strategy matrix
Exhibit 67: Eli Lilly: Opportunity assessment
Exhibit 68: Janssen Pharmaceuticals: Profile
Exhibit 69: Janssen Pharmaceuticals: Sales of CNS drugs ($ millions)
Exhibit 70: Janssen Pharmaceuticals: Metrics analysis
Exhibit 71: Janssen Pharmaceuticals: Growth strategy matrix
Exhibit 72: Janssen Pharmaceuticals: Opportunity assessment
Exhibit 73: Novartis: Profile
Exhibit 74: Novartis: Sales of few major CNS drugs ($ millions)
Exhibit 75: Novartis: Metrics analysis
Exhibit 76: Novartis growth strategy matrix
Exhibit 77: Novartis: Opportunity assessment
【レポート販売概要】
■ タイトル：中枢神経系（CNS）障害治療薬の世界市場2016-2020■ 英文：Global Central Nervous System Disorders Therapeutics Market 2016-2020
■ 発行日：2016年9月22日
■ 調査会社：Technavio
■ 商品コード：IRTNTR10192
■ 調査対象地域：グローバル
- 世界の抗菌性コーティング市場動向と予測The Antimicrobial Coatings report covers the major antimicrobials that are used to prevent or inactivate microbes, such as bacteria, fungi (including molds), and viruses. The major additives considered in this report are Silver, Copper, Zinc oxide, Zirconium, Titanium dioxide, and Zinc omadine. The market is divided further on the basis of their major applications such as Indoor air/HVAC, Medical, …
- 産業用電池の世界市場予測（～2021年）：鉛電池、ニッケル電池、リチウム電池The industrial batteries market is projected to reach USD 10.84 Billion by 2021, at a CAGR of 6.5% between 2016 and 2021. The growth of the market can be mainly attributed to the growing demand from the automotive sector, growth in the renewable energy sector, increased recycling efficiency of lead-acid and lithium-based industrial batteries, and superior performance of industrial batteries in ter …
- 自動車用死角検知の世界市場2016-2020About Automotive Blind Spot Detection Blind spot detection (BSD) systems largely belong to the advance warning and collision avoidance suite (AWCAS) of systems, which is a subset of the much larger advanced driver assistance systems (ADAS) suite. BSD systems are also known as blind spot information (BSI), side view assist (SVA), side blind zone alert (SBZA), blind spot warning (BSW), and active bl …
- 世界のCMV検査市場The report presents a detailed analysis of the Cytomegalovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the CMV definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Comm …
- クリティカル電源・冷却ソリューションの世界市場予測（～2021）：電源ソリューション（UPS、発電機）、冷却ソリューション（エアコン、チラー、冷却タワー、液冷システム）The critical power and cooling market is projected to grow at a CAGR of 8.88%, from 2016 to 2021, to reach USD 25.80 Billion by 2021. A rise in digitalization and cloud computing leading to an increase in demand for data centers, increasing demand for improved cooling efficiency in data centers, a need to reduce anomalies in power supply, and regulations and initiatives by institutes and associati …
- ヘルスケアサイバーセキュリティの世界市場展望2017-20276According to Stratistics MRC, the Global Healthcare Cyber Security Market is accounted for $6.88 billion in 2017 and is expected to reach $36.88 billion by 2026 growing at a CAGR of 20.5% during the forecast period. Increasing demand for cloud services, and rising cases of healthcare cyber-attacks are the key driving factors for the market growth. However, shortage of trained professionals is hind …
- スポーツアナリティクスの世界市場予測（～2021）The Sports Analytics market is expected to grow from USD 123.7 Million in 2016 to USD 616.7 Million by 2021, at a Compound Annual Growth Rate (CAGR) of 37.9%. Sports analytics helps various sports organizations management to analyze data from multiple sources and estimate future probabilities to improve decision making for game and business processes. Predictive analytics model is the core of spor …
- 産業用自動データ取込/認識装置の世界市場About automatic data capturing and identification systems Data capture is the mechanism of identifying and extracting data from scanned products for further processing. Automatic data capture refers to collecting data using automated data capture equipment, such as barcode readers/scanners, magnetic stripe readers, and cameras, or by using RFID technology. It requires no manual typing or punching …
- 界面活性剤の世界市場：陰イオン界面活性剤、非イオン性界面活性剤、陽イオン界面活性剤、両性界面活性剤‘Surfactants’ is a term derived from the contraction of the terms ‘SURFace ACTive Agents’. These are a group of amphiphilic organic compounds that help to lower the surface tension of a liquid or interfacial tension between two liquids. These usually act as detergents or wetting agents or emulsifiers or foaming agents. The wetting and penetration effect, emulsification, dispersion, foaming, deterg …
- IoT（モノのインターネット）の世界市場：リアルタイムストリーミング分析、セキュリティ、データ管理、遠隔モニタリング、ネットワーク帯域管理MarketsandMarkets forecasts the Internet of Things market size to grow from USD 157.05 Billion in 2016 to USD 661.74 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 33.3% from 2016 to 2021. The increasing number of connected devices and the proliferation of smartphones have contributed significantly to the rise of IoT. Rising adoption of cloud platforms, development of cheaper and smar …
- Recombinate (Hemophilia A and B)：市場予測と分析（～2022）Recombinate (Hemophilia A and B) - Forecast and Market Analysis to 2022 Summary The competitive landscape of hemophilia A and B recombinant therapy in the US and 5EU is dominated by the use of recombinant FVIII and FIX replacement factors, and patients with severe forms of the disease receive frequent prophylactic infusions beginning from the first one or two years of life and often continuing thr …
- 世界の軍用レーダ市場動向2013-2023：競合環境及び戦略的インサイトThe report provides a detailed analysis of the competitive landscape of the Military Radar market. It provides an overview of key Military Radar companies catering to the Military Radar sector, together with insights such as key alliances, strategic initiatives and a brief financial analysis.
- 世界のミサイル及びミサイル防衛システム市場：競争環境及び戦略的インサイトSynopsis This report shows the leading Missiles and Missile Defense Systems market segments in various regions across the world. Details of top companies active across the global Missiles and Missile Defense Systems market are provided, together with market size and forecast 2014-2024 for the main players across those areas. Summary The report provides a detailed analysis of the competitive landsc …
- 肺活量計の世界市場予測Spirometer Market, by Product (Hand-held, Table-top, Desktop (PC)), by Technology (Volume Measurement, Flow Measurement, Peak Flow Meters (PFM)), by End User, by Application, by Geography – Global Forecast to 2020 A spirometer is an instrument used to measure the air inhaled into and exhaled out of the lungs. It provides a simple of way of measuring lung volume and capacity, and is used in pulmona …
- インダストリアルIoTの世界市場予測（～2020）The Industrial Internet of Things (IIoT) market is expected to reach USD 151.01 Billion by 2020. IIoT is expected to generate many opportunities for various sectors such as manufacturing, metals & mining, and healthcare. It is likely to change the way production processes are executed and would benefit different businesses by enabling optimum utilization of resources, smart decision-making capabil …
